Total
0
Shares
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Infant formula producer Bubs has had a year of record growth in Australia and China
  • Speaking at the Business in China Investor Conference, Bubs says domestic revenue has more than doubled and China revenue has more than tripled
  • Direct export sales to China now make up 22 per cent of the group’s $14 million quarterly revenue
  • Bubs’ share price is up nearly half a per cent today, currently trading for $1.13 per share

At this year’s annual Australian Companies Doing Business in China Investor Conference, infant formula producer Bubs presented detailing its success in the major Asian market.

During the 2019 financial year, the company achieved record growth both domestically and in China. Revenue in Australia increased 153 per cent on the previous year and revenue in China rocketed 209 per cent.

For the first quarter of the 2020 financial year, the company’s revenue is now sitting at $14.21 million. When compared to revenue gained during the first quarter of the 2019 financial year this is a 58 per cent increase

Bubs specialise in producing organic infant formula using both goats and cow milk.

Direct sales to China now make up 22 per cent of the company’s revenue. According to Bubs, this represents its focus on building brand momentum with Chinese consumers.

“During the quarter, as the business takes shape in China, we commenced data analytics to cater for more relevant investments and granularity in achieving sustainable long-term growth,” Bubs’ Founder and CEO, Kristy Carr, said.

The data collected will assist the company plan specific regions to target and optimise supply chain planning.

“For the future, the strategic channel partnerships and rich data provide the underpinning for the increasing role that in-market marketing will play in developing the China market,” Kristy added.

Bubs’ share price is up 0.44 per cent today and currently trading for $1.13 per share.

BUB by the numbers
More From The Market Herald
Fiji Kava (ASZ:FIJ) - CEO, Anthony Noble

" Fiji Kava (ASX:FIJ) appoints Network Nutrition as US marketing partner

Medicinal kava company Fiji Kava (FIJ) has appointed Network Nutrition as their exclusive marketing partner in the United States for speciality ingredient sales.
Harris Technology (ASX:HT8) - CEO, Garrison Huang

" Harris Technology Group (ASX:HT8) achieves record quarterly sales

Harris Technology Group (HT8) achieved a record $15.1 million in quarterly sales in the September quarter.

" Qantas (ASX:QAN) and Jetstar resume international flights early

Qantas (QAN) and Jetstar are preparing to resume international flights from Sydney ahead of schedule.
Delecta (ASX:DLC) - Managing Director, Malcolm Day

" Delecta (ASX:DLC) completes drone survey at REX

Delecta (DLC) has completed a drone survey at its REX Uranium Project in Montrose County, Colorado.